Ester Siemerink
Impact in
Papers in
- Oncology 9
- Cancer survivorship and care 4
- COVID-19 and healthcare impacts 3
-
- Breast Cancer Treatment Studies 5
- Co-authors
- Geke A.P. Hospers (8 shared papers)Adrienne H. Brouwers (2 shared papers)Annemieke Cats (3 shared papers)Wouter S. Remkes (1 shared paper)Thera P. Links (1 shared paper)Elisabeth G.E. de Vries (1 shared paper)Nanno H. Mulder (4 shared papers)Helle‐Brit Fiebrich (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Clinical Oncology (2 papers)The Lancet Oncology (2 papers)International Journal of Cancer (2 papers)The Oncologist (2 papers)
- Partner nations
- NetherlandsGermanyUnited Kingdom
In The Last Decade
Ester Siemerink
27 papers receiving 1.6k citations
Ester Siemerink's Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 1.0k
- Surgery 395
- Cancer Research 127
- Pulmonary and Respiratory Medicine 240
- Pathology and Forensic Medicine 108
Countries citing papers authored by Ester Siemerink
This map shows the geographic impact of Ester Siemerink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Siemerink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Siemerink more than expected).
Fields of papers citing papers by Ester Siemerink
This network shows the impact of papers produced by Ester Siemerink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Siemerink. The network helps show where Ester Siemerink may publish in the future.
Co-authors
The 25 scholars most cited alongside Ester Siemerink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2020 | 1110 |
| 2 | 2017 | 112 | |
| 3 | 2011 | 106 | |
| 4 | 2020 | 62 | |
| 5 | 2011 | 57 | |
| 6 | 2014 | 42 | |
| 7 | 2017 | 23 | |
| 8 | 2011 | 18 | |
| 9 | 2008 | 14 | |
| 10 | 2022 | 11 | |
| 11 | 2010 | 11 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2020 | 8 | |
| 15 | 2021 | 7 | |
| 16 | 2022 | 5 | |
| 17 | 2011 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2011 | 3 | |
| 20 | 2021 | 3 |
About Ester Siemerink
Ester Siemerink is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Hepatology, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Cancer survivorship and care (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Gastric Cancer Management and Outcomes (3 papers), COVID-19 and healthcare impacts (3 papers), Cancer-related cognitive impairment studies (2 papers), Medical Imaging Techniques and Applications (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (1.0k citations), Surgery (395 citations), Cancer Research (127 citations), Pulmonary and Respiratory Medicine (240 citations) and Pathology and Forensic Medicine (108 citations). Ester Siemerink has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Geke A.P. Hospers, Adrienne H. Brouwers, Annemieke Cats, Wouter S. Remkes, Thera P. Links, Elisabeth G.E. de Vries, Nanno H. Mulder, Helle‐Brit Fiebrich, Sabine Siesling and John Theodorus Plukker. Their work appears in journals such as European Journal of Cancer, Clinical Oncology, The Lancet Oncology, International Journal of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.